Needham Maintains Buy on Enovis, Lowers Price Target to $34
Needham analyst Mike Matson maintains Enovis (NYSE:ENOV) with a Buy and lowers the price target from $52 to $34.
Stocks · News reference
Enovis Enters Into Binding Offer To Acquire eCential Robotics For Upfront Enterprise Value Of €155 Mln
Enhances Enovis’ enabling technology ecosystem to include robotic automation capabilities, empowering surgeons with a broader, integrated set of precision tools in the operating room. Creates a robotics center of
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Transcript: Enovis Q2 2026 Earnings Conference Call
Enovis (NYSE:ENOV) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. Benzinga APIs provide real-time access to earnings
Wells Fargo Maintains Overweight on Enovis, Lowers Price Target to $33
Citizens Maintains Market Outperform on Enovis, Lowers Price Target to $47
Citizens analyst David Turkaly maintains Enovis (NYSE:ENOV) with a Market Outperform and lowers the price target from $55 to $47.